mirabegron 50 MG 24 HR Extended Release Oral Tablet

RxCUI: 1300801
RxNorm name: mirabegron 50 MG 24 HR Extended Release Oral Tablet
Display name: mirabegron 50 MG 24 HR Extended Release Oral Tablet
Full name: mirabegron 50 MG 24 HR Extended Release Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:49

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 10 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
MIRABEGRON	MIRABEGRON	REMEDYREPACK INC.	d0054db9-e38a-4786-be2c-996fa5b8f47d	2026-05-22	Warnings, Adverse reactions	Exact identifier rxcui: 1300801
Mirabegron	MIRABEGRON	Amneal Pharmaceuticals NY LLC	e597023d-6dcc-4d9e-8ce0-2d28a5d862f3	2026-03-26	Warnings, Adverse reactions	Exact identifier rxcui: 1300801
MIRABEGRON	MIRABEGRON	Lupin Pharmaceuticals, Inc.	d22d3d12-8466-46db-bc19-d13e87c6115c	2025-12-24	Warnings, Adverse reactions	Exact identifier rxcui: 1300801
Mirabegron	MIRABEGRON	Qilu Pharmaceutical Co., Ltd.	98247602-29b9-4621-8eeb-519e40b883b9	2025-10-21	Warnings, Adverse reactions	Exact identifier rxcui: 1300801
Mirabegron	MIRABEGRON	REMEDYREPACK INC.	5f7a1758-8691-4e53-96d6-a01626ee8140	2025-10-02	Warnings, Adverse reactions	Exact identifier rxcui: 1300801
MIRABEGRON	MIRABEGRON	Bryant Ranch Prepack	00826723-d25e-498a-b8d4-d17e5c14dda5	2025-09-26	Warnings, Adverse reactions	Exact identifier rxcui: 1300801
MIRABEGRON	MIRABEGRON	Bryant Ranch Prepack	1a7337a4-2901-4e65-b666-7623fadb78f2	2025-09-26	Warnings, Adverse reactions	Exact identifier rxcui: 1300801
Mirabegron	MIRABEGRON	Zydus Lifesciences Limited	461b2b94-205a-4860-9cb4-d30267ada9df	2024-10-09	Warnings, Adverse reactions	Exact identifier rxcui: 1300801
Mirabegron	MIRABEGRON	Zydus Pharmaceuticals (USA) Inc.	2e40eb74-3b2a-47f7-bf31-fe27484f9bd2	2024-10-09	Warnings, Adverse reactions	Exact identifier rxcui: 1300801
Myrbetriq	MIRABEGRON	Astellas Pharma US, Inc.	ba9e9e15-e666-4c56-9271-2e24739cfa2d	2024-08-01	Warnings, Adverse reactions	Exact identifier rxcui: 1300801

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 10 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
00826723-d25e-498a-b8d4-d17e5c14dda5	mirabegron 50 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR mirabegron 50 MG Extended Release Oral Tablet [SCD] · mirabegron 50 MG 24 HR Extended Release Oral Tablet [SY]	3	100	These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012	20250926
1a7337a4-2901-4e65-b666-7623fadb78f2	mirabegron 50 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR mirabegron 50 MG Extended Release Oral Tablet [SCD] · mirabegron 50 MG 24 HR Extended Release Oral Tablet [SY]	3	100	These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012	20250926
d22d3d12-8466-46db-bc19-d13e87c6115c	mirabegron 50 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR mirabegron 50 MG Extended Release Oral Tablet [SCD] · mirabegron 50 MG 24 HR Extended Release Oral Tablet [SY]	3	19	These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012	20251224
ba9e9e15-e666-4c56-9271-2e24739cfa2d	mirabegron 50 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR mirabegron 50 MG Extended Release Oral Tablet [SCD] · mirabegron 50 MG 24 HR Extended Release Oral Tablet [SY]	3	17	These highlights do not include all the information needed to use MYRBETRIQ ® /MYRBETRIQ ® GRANULES safely and effectively. See full prescribing information for MYRBETRIQ/MYRBETRIQ GRANULES. MYRBETRIQ (mirabegron extended-release tablets), for oral use MYRBETRIQ GRANULES (mirabegron for extended-release oral suspension) Initial U.S. Approval: 2012	20240801
e597023d-6dcc-4d9e-8ce0-2d28a5d862f3	mirabegron 50 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR mirabegron 50 MG Extended Release Oral Tablet [SCD] · mirabegron 50 MG 24 HR Extended Release Oral Tablet [SY]	3	4	These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012	20260326
5f7a1758-8691-4e53-96d6-a01626ee8140	mirabegron 50 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR mirabegron 50 MG Extended Release Oral Tablet [SCD] · mirabegron 50 MG 24 HR Extended Release Oral Tablet [SY]	3	3	These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012	20251002
2e40eb74-3b2a-47f7-bf31-fe27484f9bd2	mirabegron 50 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR mirabegron 50 MG Extended Release Oral Tablet [SCD] · mirabegron 50 MG 24 HR Extended Release Oral Tablet [SY]	3	3	These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012	20241009
461b2b94-205a-4860-9cb4-d30267ada9df	mirabegron 50 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR mirabegron 50 MG Extended Release Oral Tablet [SCD] · mirabegron 50 MG 24 HR Extended Release Oral Tablet [SY]	3	3	These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012	20241009
d0054db9-e38a-4786-be2c-996fa5b8f47d	mirabegron 50 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR mirabegron 50 MG Extended Release Oral Tablet [SCD] · mirabegron 50 MG 24 HR Extended Release Oral Tablet [SY]	3	1	These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012	20260522
98247602-29b9-4621-8eeb-519e40b883b9	mirabegron 50 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR mirabegron 50 MG Extended Release Oral Tablet [SCD] · mirabegron 50 MG 24 HR Extended Release Oral Tablet [SY]	3	1	These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS. MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012	20251021